Skip to the main content.
Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

Turn Our Insights Into Your Impact

From early feasibility to commercialization, progress depends on the right decisions at the right time. Get confident in your next step with blogs, case studies, and expert insights that cut through complexity and move development forward.

 

Miyuru Amarapala

Miyuru Amarapala, MD, is a Product Commercialization Manager, in the Commercial Strategy and Market Access practice at Veranex, where she specializes in evidence strategy, health economics, and market access for medical device and diagnostic innovators. Dr. Amarapala works with companies from early development through commercialization to design evidence generation strategies that satisfy regulatory, payer, clinical, and patient stakeholder requirements. Her expertise spans cardiovascular, neurovascular, and diagnostic technologies, with particular focus on helping international companies navigate US market access complexities. She holds an MD and an MSc in International Health Policy.